Kenya's rollout of the groundbreaking HIV prevention drug lenacapavir is failing to reach high-risk areas like Kibera. Despite its potential, high transport costs and clinic exclusions leave the most vulnerable without access, highlighting an equity gap in healthcare delivery.
HIV Prevention Shot Fails Kenyas Poorest
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →